In the heart, pharmacological inhibition of mTOR with rapamycin reverses cardiac hypertrophy induced by Akt overexpression (Shioi et al., 2002; Shiojima et al., 2015). The gene discussed is AKT1; the disease is cardiac hypertrophy.